SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000885
Filing Date
2024-05-15
Accepted
2024-05-15 17:00:40
Documents
79
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240331x10q.htm   iXBRL 10-Q 1314052
2 EX-31.1 tmb-20240331xex31d1.htm EX-31.1 13086
3 EX-31.2 tmb-20240331xex31d2.htm EX-31.2 12979
4 EX-32 tmb-20240331xex32.htm EX-32 10009
  Complete submission text file 0001410578-24-000885.txt   6567098

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20240331.xsd EX-101.SCH 63921
6 EX-101.CAL tmb-20240331_cal.xml EX-101.CAL 54183
7 EX-101.DEF tmb-20240331_def.xml EX-101.DEF 171696
8 EX-101.LAB tmb-20240331_lab.xml EX-101.LAB 514230
9 EX-101.PRE tmb-20240331_pre.xml EX-101.PRE 344423
83 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240331x10q_htm.xml XML 1024337
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39752 | Film No.: 24952294
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)